Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from NICE

Prostate cancer screenings could save lives but experts warn of major risks

Prostate cancer is the most common cancer among men in the UK, with more than 64,000 diagnoses anually

The Independent UK

Prostate cancer drug that can halve death risk to be offered to thousands in England

At least 6,000 men a year with hormone-sensitive cancer to get access to darolutamide, which blocks growth with fewer side-effects

The Guardian - UK

Prostate cancer sufferers in ‘postcode lottery’ to get new drug, says charity

It comes as concerns were raised that a new drug approved for NHS use will not be given to eligible patients.

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

New ‘gentler’ treatment for prostate cancer gets green light but not all men will have access to it

It comes as concerns were raised that a new drug approved for NHS use will not be given to eligible patients

The Independent UK

UK Health Agency Recommends GSK-Backed ViiV Healthcare's Apretude As Injectable HIV Treatment

The U.K.’s National Institute for Health and Care Excellence (NICE) is recommending a treatment from a firm jointly owned by GSK Plc (NYSE:GSK), Pfizer Inc (NYSE:PFE) and Shionogi Inc.

Benzinga

England and Wales to get long-lasting HIV prevention jab for first time

The drug, known as cabotegravir, must be administered every two months.

Euronews

‘Gamechanging’ HIV prevention jab to be approved for England and Wales

Long-acting injection offers alternative to daily pills taken to protect against the virus

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

‘Game-changing’ HIV jab to be offered in England and Wales

The rollout is expected to begin around three months after Nice publishes its final guidance later this year

The Independent UK

‘Game-changing’ HIV prevention jab to be offered in England and Wales

The National Institute for Health and Care Excellence recommended the injection for people at risk of HIV who are unable to take oral PrEP.

Evening Standard

Brain cancer patients left ‘devastated’ as new drug is rejected for NHS use

Patients who have taken the drug in clinical trials report remarkable results, including their tumours shrinking

The Independent UK

Patients with brain cancer express disappointment after drug rejected for NHS

Patients who have taken the drug in clinical trials report remarkable results, including their tumours shrinking.

Evening Standard

Almost 300,000 protest against pushing up NHS drug prices

Campaign group 38 Degrees said the Government ‘must reject demands for higher prices for vital NHS medicine’.

The Independent UK

‘It May Not Be So Easy’—Marsch Copes With Canada Injuries Ahead of 2026 World Cup

Canada will be without three key defenders for the second straight window as the World Cup nears.

Sports Illustrated

Researchers warn doctors could be ‘overtesting’ for prostate cancer

PSA testing remains controversial because it can lead to healthy men being diagnosed and treated unnecessarily

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Trump pressure to hike UK drug prices could cost NHS billions, experts warn

Anew deal will only trigger further increased price demands and make healthcare in the UK more expensive, say experts

The Guardian - UK

NHS could pay 25% more for medicines under plan to end row with drugmakers and Trump

UK ministers preparing to raise payments to end standoff with pharma industry, cited as reason for firms axing British investments

Evening Standard

Change to NHS drug analysis on the table to stave off US tariffs – reports

It is understood plans have been outlined to increase the amount the health service pays for medicines.

Evening Standard

Will Paul Pogba make his return to football against Tottenham after injury nightmare and ban?

The former Manchester United and Juventus star has suffered a setback on his bid return to action

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

The UK must invest in medicines – but not at any price

The UK’s science minister, Sir Patrick Vallance, has sounded the alarm over the country’s declining investment in medicines. He warned that the NHS risks losing out on important treatments and the country could lose its place at the cutting edge of medical research if spending does not recover. It comes…

International Business Times

Forest Denied Winning European Return By Antony, Roma Down Nice

Antony's late goal denied Nottingham Forest a winning return to European football as Real Betis grabbed a 2-2 draw in their Europa League opener on Wednesday, while Roma won at Nice.

The Independent UK

NHS risks missing ‘new era’ of Alzheimer’s treatment without major reforms, experts warn

A new ‘medical revolution’ in treating Alzheimer’s disease is coming, a leading professor says

Evening Standard

NHS ‘not ready’ for new era of Alzheimer’s diagnosis and treatment, experts say

It comes as a series of papers by 40 experts said a ‘concerted societal effort’ is needed to ensure patients benefit fully from scientific advances.

The Guardian - UK

NHS drug pricing is all about the art of the deal

Letter: Better negotiation with big pharma could ease the process, writes Andrew Dillon, in response to an article by Polly Toynbee about Donald Trump’s complaints about NHS pricing

The Guardian - UK

Who benefits if NHS drug prices soar? Donald Trump and big pharma. Just one more way he’s menacing Britain

The NHS needs cheap drugs, and our economy needs a thriving pharma industry. The president threatens both – no wonder Labour is grovelling to him, says Guardian columnist Polly Toynbee

The Guardian - UK

NHS access to promising sleeping pill daridorexant is patchy, say doctors

Prescribing of non-addictive drug in England clustered in London and West Midlands, with cheaper alternative issued far more often

1 … 5 6 7 8

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.